David Moatazedi
Directeur Général chez EVOLUS, INC.
Fortune : 8 M $ au 30/04/2024
Postes actifs de David Moatazedi
Sociétés | Poste | Début | Fin |
---|---|---|---|
EVOLUS, INC. | Directeur/Membre du Conseil | 06/05/2018 | - |
Directeur Général | 06/05/2018 | - | |
President | 06/05/2018 | - | |
BIOMERICA, INC. | Directeur/Membre du Conseil | 07/12/2022 | - |
Independent Dir/Board Member | 07/12/2022 | - |
Historique de carrière de David Moatazedi
Anciens postes connus de David Moatazedi
Sociétés | Poste | Début | Fin |
---|---|---|---|
RESHAPE LIFESCIENCES INC. | Directeur/Membre du Conseil | 13/03/2017 | 30/06/2020 |
Independent Dir/Board Member | 13/03/2017 | 30/06/2020 | |
ALLERGAN, INC. | Corporate Officer/Principal | 01/02/2013 | 01/05/2018 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/06/2002 | 01/03/2005 |
Formation de David Moatazedi
Pepperdine University | Masters Business Admin |
The California State University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
Director/Board Member | 3 |
Independent Dir/Board Member | 2 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
EVOLUS, INC. | Health Technology |
BIOMERICA, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Obalon Therapeutics, Inc.
Obalon Therapeutics, Inc. Medical SpecialtiesHealth Technology Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then remotely inflated. The company was founded on January 2, 2008 and is headquartered in Carlsbad, CA. | Health Technology |
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
- Bourse
- Insiders
- David Moatazedi
- Expérience